In vivo function of MeTro sealants using rat incision model of lungs

Slides:



Advertisements
Similar presentations
Fig. 1. TP is highly expressed in myeloma.
Advertisements

Examples of functional imaging biomarkers in two DCA responders
Fig. 4. Primary human metastatic melanomas contain CCL21-expressing LECs, and expression of VEGFC positively correlates with hallmarks of tumor inflammation.
Fig. 6. AZD6738 induces DNA damage and apoptosis and exhibits antitumor efficacy in xenograft models of high-risk medulloblastoma and neuroblastoma. AZD6738.
Fig. 5. Circulating PPi concentration does not correlate with severity of calcification phenotype in mice. Circulating PPi concentration does not correlate.
Fig. 6. Ex vivo and in vivo test to evaluate the sealing capability of the MeTro sealant using a porcine lung incision model. Ex vivo and in vivo test.
Fig. 7. Role of PDE5 up-regulation in lung cancer–associated PH.
Fig. 4. Ex vivo and in vivo function of the MeTro sealant using rat incision model of arteries. Ex vivo and in vivo function of the MeTro sealant using.
Fig. 1. BCAS1 expression identifies newly generated oligodendrocytes.
Fig. 4. Biomechanical properties of treated tibiae.
Fig. 4. aPD-1 mAb transfer to macrophages is mediated by FcγRs.
Fig. 5. Prophylactic treatment with GS-5734 reduces SARS-CoV disease.
Fig. 3. A circadian rhythm in fibroblast wound-healing response.
Fig. 4 Infection-induced CLV dysfunction is associated with decreased LMC coverage. Infection-induced CLV dysfunction is associated with decreased LMC.
Fig. 2. In vitro sealing properties of the MeTro sealant.
Fig. 2. GPC3 expression in normal and tumor tissues.
Fig. 5. Antitumor efficacy of ERY974 in immunocompetent human CD3 transgenic mice. Antitumor efficacy of ERY974 in immunocompetent human CD3 transgenic.
Fig. 6. Effects of CD31-NP targeting in perfused human kidneys.
Fig. 4. Specific versus nonspecific NP accumulation.
Fig. 5. Preliminary performance validation of the hydrogel in vivo in a rabbit model of scleral trauma. Preliminary performance validation of the hydrogel.
Fig. 1. CD31 is present throughout the human renal vasculature.
Fig. 1. Aberrant JNK pathway activation in mouse models of ALS and in spinal cord tissue from patients with sporadic ALS. Aberrant JNK pathway activation.
Immunofluorescence staining of virus-infected human placental explants
Fig. 7 Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors. Gel scaffold for inhibition of postsurgical recurrence of B16F10 tumors.
Fig. 5. In vivo characterization of adipogenesis by CT.
Fig. 6. A circadian rhythm in keratinocyte wound healing and a diurnal variation in human burn healing outcome. A circadian rhythm in keratinocyte wound.
Fig. 2 In vitro assessment of hESC-RPE cell sheets.
Fig. 2. Vascular inflammation blocks perivascular adipocyte differentiation through paracrine signals. Vascular inflammation blocks perivascular adipocyte.
Fig. 6. Apoptotic MSCs exert in vivo immunosuppression in a TH2-type inflammation model in the absence of cytotoxic cells. Apoptotic MSCs exert in vivo.
Fig. 4. Actin polymerization rhythms are required for circadian regulation of adhesion and wound-healing efficacy by fibroblasts. Actin polymerization.
Persistence of CAR4 cells is reduced after sustained TCR engagement
Fig. 7 BRD0705 impairs colony formation in AML cell lines and patient cells and shows in vivo efficacy in multiple AML mouse models. BRD0705 impairs colony.
Fig. 3 hESC-RPE cell sheet transplantation and validation of the surgical method. hESC-RPE cell sheet transplantation and validation of the surgical method.
Fig. 7. KIF11 informs patient prognosis, and targeting improves survival in a preclinical model. KIF11 informs patient prognosis, and targeting improves.
Fig. 1. mGlu7 expression is reduced in RTT autopsy samples.
Fig. 1. Neurobehavioral testing in YG8R mice transplanted with wild-type mouse HSPCs. Neurobehavioral testing in YG8R mice transplanted with wild-type.
Role of immune and inflammatory cells in lung cancer–associated PH
Fig. 4. Identification of GRP78 as the target antigen of NMO-rAbs ON and ON Identification of GRP78 as the target antigen of NMO-rAbs.
Fig. 5 Local gel scaffold for T cell memory response.
Fig. 2 Fas controls IL-1RA–sEV secretion in murine MSCs.
Fig. 7 Improvement of clinical score and axon pathology by nasal IL-4 treatment during chronic EAE. Improvement of clinical score and axon pathology by.
Fig. 5. Nutlin-3 treatment rescues the proliferation and differentiation of NPCs in vitro. Nutlin-3 treatment rescues the proliferation and differentiation.
Fig. 2. IL-2/rapamycin–expanded T cells express homing receptors to traffic to lymphoma sites and are resistant to SN-38 toxicity. IL-2/rapamycin–expanded.
Fig. 4. Features of PH in LLC1 lung tumor mice.
Fig. 3 CSF1 is expressed in human melanoma.
Fig. 4. Local application of FR provides prolonged protection against Gq-dependent airway constriction in normal and OVA-sensitized mice in vivo. Local.
Fig. 6 Photoreceptor cell survival in the RCS rat retina after transplantation with hESC-RPE cell sheets. Photoreceptor cell survival in the RCS rat retina.
Fig. 5 BRD0705 induces differentiation in AML cell lines and primary patient samples through GSK3α-selective inhibition. BRD0705 induces differentiation.
Fig. 3 Activation of freshly isolated CD4+ T cells from HIV-infected patients on ART selectively reverses baseline blocks to splicing, elongation, and.
CSF1 secretion by melanoma cells is induced by CTL-derived cytokines
Correlation of reovirus RNA/protein with proliferating tumor cells
Fig. 1 Neutrophils derived from patients with MPNs are associated with an increase in NET formation and a prothrombotic, NET-rich phenotype. Neutrophils.
Fig. 6 Combination therapy with LVSOD2 and LVshCTGF preserves flap volume and reduces fibrosis after RT. Combination therapy with LVSOD2 and LVshCTGF preserves.
Fig. 4 Lentiviral transgene expression penetrates tissue and provides durable effects in vivo. Lentiviral transgene expression penetrates tissue and provides.
Fig. 1 Device structure, typical output performance, and cytocompatibility of BD-TENG. Device structure, typical output performance, and cytocompatibility.
Biocompatibility evaluation in vivo with a mouse subcutaneous implant
Fig. 1. MSCs undergo in vivo apoptosis after infusion without affecting immunosuppression. MSCs undergo in vivo apoptosis after infusion without affecting.
Fig. 6. Ex vivo and in vivo test to evaluate the sealing capability of the MeTro sealant using a porcine lung incision model. Ex vivo and in vivo test.
Fig. 1. CAR4 and CAR8 cells demonstrate in vitro and in vivo antileukemic efficacy. CAR4 and CAR8 cells demonstrate in vitro and in vivo antileukemic efficacy.
Fig. 1. DEL-1 is expressed by human and mouse osteoclasts.
Fig. 6 Activating IRF8 promotes macrophage migration during the recovery phase after SCI. Activating IRF8 promotes macrophage migration during the recovery.
Fig. 1. Matrix stiffness sensitizes myofibroblasts to apoptosis induced by inhibition of their mechanotransduction pathways. Matrix stiffness sensitizes.
Fig. 6 Antitumor effect on tumor growth and pulmonary metastasis of CSSD-9 in vivo. Antitumor effect on tumor growth and pulmonary metastasis of CSSD-9.
Fig. 6 MSC encapsulation in vitro within PdBT cross-linked gels.
Fig. 6 Pig 5 tissue development.
Fig. 7 BEL immune response.
Fig. 5 Reconstitution of the dormant state using fetal ovaries.
Fig. 3. Col IV–Ac2-26 NPs suppress lesional superoxide and increase lesional Il10 mRNA in Ldlr−/− mice with established atherosclerosis. Col IV–Ac2-26.
Fig. 2. In vitro sealing properties of the MeTro sealant.
In vivo function of MeTro sealants using rat incision model of lungs
Presentation transcript:

Fig. 5. In vivo function of MeTro sealants using rat incision model of lungs. In vivo function of MeTro sealants using rat incision model of lungs. (A) In vivo tests on rat lungs sealed by MeTro. (i) Schematic diagram showing the experimental setup. (ii) Image of the sealed lung pressurized with air, demonstrating that MeTro could adhere to the lung surface and seal the incision, but the lung tissue burst from other areas (the source of the bubbles) when pressures of >5.5 kPa were applied. (iii) Burst pressure values for lungs sealed with the MeTro sealant on day 0 (n = 4) and day 4 (n = 3) as compared to lungs sealed by Evicel (n = 3), Progel (n = 6), and suture only (n = 6) as well as healthy lung (n = 3) on day 0. Representative (B) SEM and (C) H&E-stained images from the interface between the explanted rat lung and the MeTro sealant. Tight interfaces between the MeTro hydrogel and the tissues indicate strong bonding and interlocking at the interfaces. (D) H&E staining of MeTro sections at days (i) 7 and (ii) 28 and MeTro-MMP sections at days (iii) 7 and (iv) 28 after sealing. (E) Fluorescent immunohistochemical analysis of the MeTro and MeTro-MMP sealants, showing no significant local lymphocyte infiltration (CD3) at days (i) 7 and (ii) 28 for MeTro samples and at days (iii) 7 and (iv) 28 for MeTro-MMP samples. Also, the images exhibit remarkable macrophage (CD68) expression at day 7 (i and iii) but reduced expression at day 28 for MeTro and remained the same for MeTro-MMP samples (ii and iv). Green, red, and blue colors in (E) represent the macrophages, lymphocytes, and cell nuclei (DAPI), respectively. Data are means ± SD. P values were determined by one-way ANOVA followed by Tukey’s multiple comparisons test for (A) (**P < 0.01, ***P < 0.001). Nasim Annabi et al., Sci Transl Med 2017;9:eaai7466 Published by AAAS